Glass House Brands Inc. Subordinate Voting Shares (AMEX: GLAS) Stock Analysis & Fundamentals

GLASGlass House Brands Inc. Subordinate Voting Shares

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · glasshousebrands.com

9.710USD+0.10%Mkt Cap: 869.92M $P/E: —1d ago

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packa…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap869.92M $

Enterprise Value1.07B $

Revenue (TTM)177.68M $

Gross Profit76.96M $

Net Income (TTM)-29.66M $

Revenue/Share2.130 USD

Last Price9.710 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees357

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)41.60

PEG—

EV/EBITDA-98.26

EV/Revenue6.00

P/S4.72

P/B10.31

EPS (TTM)-0.80

EPS (Forward)0.23

52W Range

5.15052% of range13.93

52W High13.93 USD

52W Low5.150 USD

Profitability

Gross Margin42.29%

Oper. Margin-35.42%

EBITDA Margin-6.11%

Profit Margin-16.30%

ROE-40.11%

ROA-9.31%

Growth

Revenue Growth-9.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF11.45M $

CapEx (TTM)27.18M $

FCF Margin-14.71%

FCF Yield-3.00%

Net Debt50.62M $

Net Debt/EBITDA-4.66

Balance Sheet

Debt/Equity1.01

Current Ratio1.85

Quick Ratio0.79

Book Value/Sh0.9080 USD

Cash/Share0.2880 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)16.00 USD

Upside (mean)+64.8%

Target Range15.00 USD – 17.00 USD

$15.00+64.8% to mean$17.00

# Analysts3

Ownership

Shares Out.83.44M

Float65.75M

Insiders7.86%

Institutions21.14%

Short Interest

Short Ratio0.7d

Short % Out.0.34%

Shares Short144.17K

Short (prev mo.)78.58K

Technical

SMA 5011.26 (-13.8%)

SMA 2009.144 (+6.2%)

Beta0.64

S&P 52W Chg20.80%

Avg Vol (30d)349.74K

Avg Vol (10d)347.45K

Technical Indicators

RSI (14)43.7

MACD-0.3551

MACD Signal-0.3979

MACD Hist.+0.0427

BB Upper10.66 USD

BB Middle9.922 USD

BB Lower9.183 USD

BB Width14.90%

ATR (14)0.6594 USD

Vol Ratio (20d)0.91x